Ingersoll Rand To Acquire Howden Roots From Chart Industries For About $300 Mln Cash

Ingersoll Rand, Inc. (IR) entered into a definitive agreement to acquire Howden Roots LLC from Chart Industries, Inc. (GTLS) for an all-cash purchase price of approximately $300 million. Roots is a leading provider of low-pressure compression and vacuum technologies.

The acquisition adds long-standing premium brand with complementary low-pressure compression and vacuum technologies. It also enhances Ingersoll Rand’s capabilities to serve high growth, sustainable end markets including green steel

This acquisition is expected to close in the third quarter 2023 upon obtaining required regulatory approvals. Upon close, Roots will join Ingersoll Rand’s IT&S segment.

Oracle Climbs On Analyst Action Ahead Of Quarterly Results

Oracle Corp. (ORCL) shares are gaining more than 4 percent on Monday morning trade after Wolfe Research raised its rating to Outperform from Peer Perform. The tech-giant has scheduled its quarterly results today. The shares have reached a 5-year high today.

Oracle and other firms had invested $270 million in tech startup Cohere, a business rival to Microsoft supported OpenAI on Thursday.

Currently, shares are at $115.02, up 4.68 percent from the previous close of $109.85 on a volume of 5,212,759.

Nasdaq Stock Slips 10% On Adenza Acquisition Deal

Shares of Nasdaq, Inc. (NDAQ) are slipping nearly 10% after the company announced a deal to buy Adenza from software investment firm Thoma Bravo for $10.5 billion in cash and shares of common stock.

NDAQ is currently trading at $52.21, down $5.62 or 9.72%, on the Nasdaq. The stock opened its trading at $52.10 after closing Friday’s trading at $57.83. The stock has traded between $48.06 and $69.22 in the past 52-week period.

The deal is comprised of $5.75 billion in cash and 85.6 million shares of Nasdaq stock.

Adenza is a provider of mission-critical risk management and regulatory software to the financial services industry. The acquisition is expected to close within six to nine months.

According to Nasdaq, the deal will improve its margins and revenue quality and deliver adjusted earnings per share accretion by the end of year two.

Shots fired at moving car in Aurora leave two men hospitalized

Two men were shot inside a car traveling along Hampden Avenue near Parker Road Sunday night, according to Aurora police.

The men were hospitalized with serious injuries, and a third man in the car suffered minor injuries, the police said in a posting on Twitter.

The shooting happened as the vehicle was moving, police said. They closed off access to Hampden near the intersection with Parker Road late Sunday. Police appealed for public help as they investigate the circumstances leading to the shooting, asking that witnesses or anybody with information contact the police department.

Intapp Rally Continues

Shares of Intapp, Inc. (INTA) are gaining more than 9 percent on Monday morning continuing a rally since the last week of May 18 when the announced the pricing of its public offering. There have been no corporate announcements from the cloud software firm to influence its stock movement today.

Currently, shares are at $48.00, up 9.07 percent from the previous close of $44.01 on a volume of 469,732.

Ukraine Claims To Have Regained 4 Donetsk Villages In Counter-offensive

Ukraine claims to have liberated four villages in the Donestk region.

Reports quoting Ukrainian defense and military officials said their forces have recaptured the frontline villages of Blahodatne, Makarivka, Neskuchne and Storozhove.

However, Russia hasn’t yet confirmed if its forces have retreated from the relatively small villages.

President Volodymyr Zelensky said at the weekend that Ukraine’s long-awaited counter-offensive has started.

Ukrainian forces had begun advancing in the country’s south a week ago.

Russia has reportedly blown up another dam in the Russian-controlled region in the southeast along the border between Donetsk and Zaporizhzhia.

Intense fighting is going on between Russian and Ukrainian forces in the region, reports say.

Russia is on the defensive, according to the Ukrainian Armed Forces.

The two sides exchanged nearly 200 prisoners of war Sunday, according to officials in Moscow and Kyiv.

Meanwhile, Dutch open-source intelligence website Oryx reported that Ukraine has lost 16 Bradley infantry fighting vehicles, supplied by the United States, in the past few days.

GM To Inject Over $1 Bln To Michigan Facility For Heavy-Duty Pickups

General Motors Co. (GM) announced on Monday that it will allocate over $1 billion in funding to Flint Assembly and Flint Metal Center Michigan factories to manufacture next-generation heavy-duty internal combustion engine trucks.

As part of the investment, General Motors will allocate $788 million to upgrade its Flint Assembly plant to produce heavy-duty gas and diesel trucks. An additional $233 million will be invested in the Flint Metal Center, which will assist in the manufacturing of these vehicles. Both facilities are situated in mid-Michigan.

During the year 2022, General Motors witnessed a 38 percent growth in sales of heavy-duty pickups compared to the previous year. This resulted in the sale of nearly 288 thousand trucks.

The announcement of the investment precedes the upcoming contract negotiations between the Detroit automakers, including General Motors, and the United Auto Workers union, scheduled to take place this summer.

Marker Therapeutics Up 34% After First Patient Dosed In Phase 1 Trial Of MT-601

Shares of Marker Therapeutics, Inc. (MRKR) are up 34% on Monday morning trade as the clinical-stage immuno-oncology company announced that the first patient with lymphoma has been treated in the company-sponsored clinical trial of Phase 1 multicenter APOLLO trial investigating MT-601.

MRKR is trading on the Nasdaq at $3.38, up 34.74% or $0.87 per share. It has traded between $0.67 and $6.60 in the past 52-week period.

The APOLLO trial sponsored by Marker assessed MT-601 in patients with lymphoma who have either relapsed after anti-CD19 CAR T cell therapy or were ineligible to receive it.

After the positive TACTAL trial results, which targeted five tumor-associated antigens, Marker stated that broadening its multiTAA-specific T cell product to target six antigens could result in better and more durable responses due to its ability to overcome antigen loss by targeting more than one antigen.